Biomarkers identified for cytokine release syndrome risk after CAR T-cell therapy
For patients with autoimmune disease, higher baseline B-cell counts and systemic inflammation are associated with development of cytokine release syndrome (CRS) after chimeric antigen receptor (CAR) T-cell therapy, according ...
Oct 26, 2026
0
3









